{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:16:02Z","timestamp":1790057762033,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005632","name":"Narodowe Centrum Bada\u0144 i Rozwoju","doi-asserted-by":"publisher","award":["PBS\/A8\/36\/2015"],"award-info":[{"award-number":["PBS\/A8\/36\/2015"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["MSCA-ITN-2014-ETN"],"award-info":[{"award-number":["MSCA-ITN-2014-ETN"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["642881"],"award-info":[{"award-number":["642881"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006445","name":"Uniwersytet Warszawski","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011755","name":"National Center for Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011755","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bioorg.2019.103365","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T12:02:19Z","timestamp":1571400139000},"page":"103365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors"],"prefix":"10.1016","volume":"94","author":[{"given":"Alexandra","family":"Bertran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danylo","family":"Khomiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Konopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Rejmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Bulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Seco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Tarrag\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Prades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103365_b0005","doi-asserted-by":"crossref","unstructured":"H. Huang, Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances, 9 (2018) 5\u20137. http:\/\/doi.org\/10.3390\/s18103249.","DOI":"10.3390\/s18103249"},{"key":"10.1016\/j.bioorg.2019.103365_b0010","doi-asserted-by":"crossref","unstructured":"M.W. Roomi, J.C. Monterrey, T. Kalinovsky, M. Rath, A. Niedzwiecki, Patterns of MMP-2 and MMP-9 expression in human cancer cell lines, (2009) 1323\u20131333. http:\/\/doi.org\/10.3892\/or.","DOI":"10.3892\/or"},{"key":"10.1016\/j.bioorg.2019.103365_b0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.gendis.2014.12.002","article-title":"Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas","volume":"2","author":"Cathcart","year":"2015","journal-title":"Genes Dis."},{"key":"10.1016\/j.bioorg.2019.103365_b0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/10409238.2013.770819","article-title":"Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade","volume":"48","author":"Vandooren","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2019.103365_b0025","doi-asserted-by":"crossref","first-page":"15337","DOI":"10.1523\/JNEUROSCI.3467-10.2010","article-title":"Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?","volume":"30","author":"Rivera","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103365_b0030","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrn1807","article-title":"Metalloproteinases: Mediators of pathology and regeneration in the CNS","volume":"6","author":"Yong","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103365_b0035","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1523\/JNEUROSCI.4359-05.2006","article-title":"Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory","volume":"26","author":"Nagy","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103365_b0040","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers","volume":"36","author":"Rempe","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bioorg.2019.103365_b0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.18388\/pb.2018_134","article-title":"Matrix metalloproteinase 9 and epileptogenesis - the crucial role of the enzyme and strategies to prevent the disease development","volume":"64","author":"Khomiak","year":"2018","journal-title":"Postep. Biochem."},{"key":"10.1016\/j.bioorg.2019.103365_b0050","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1523\/JNEUROSCI.2751-17.2018","article-title":"Matrix metalloproteinase-mediated blood-brain barrier dysfunction in epilepsy","volume":"38","author":"Rempe","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2019.103365_b0055","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1523\/JNEUROSCI.22-03-00920.2002","article-title":"Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus","volume":"22","author":"Szklarczyk","year":"2002","journal-title":"Neuroscience."},{"key":"10.1016\/j.bioorg.2019.103365_b0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.mehy.2010.09.013","article-title":"Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy","volume":"76","author":"Yin","year":"2011","journal-title":"Med. Hypotheses."},{"key":"10.1016\/j.bioorg.2019.103365_b0065","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1083\/jcb.200708213","article-title":"Important role of matrix metalloproteinase 9 in epileptogenesis","volume":"180","author":"Wilczynski","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bioorg.2019.103365_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40348-014-0006-y","article-title":"Matrix metalloproteinases and epileptogenesis","volume":"1","author":"Ikonomidou","year":"2014","journal-title":"Mol. Cell. Pediatr."},{"key":"10.1016\/j.bioorg.2019.103365_b0075","first-page":"392","article-title":"Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment","volume":"35","author":"Goldenberg","year":"2010","journal-title":"P&T a Peer-Reviewed J. Formul. Manag."},{"key":"10.1016\/j.bioorg.2019.103365_b0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13311-013-0252-z","article-title":"Anti-epileptogenic clinical trial designs in epilepsy: issues and options","volume":"11","author":"Schmidt","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bioorg.2019.103365_b0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.matbio.2015.01.002","article-title":"New strategies for targeting matrix metalloproteinases","volume":"44","author":"Fields","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bioorg.2019.103365_b0090","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/17460441.2011.560936","article-title":"New opportunities in drug design of metalloproteinase inhibitors: combination between structure\u2013function experimental approaches and systems biology","volume":"6","author":"Sela-Passwell","year":"2011","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103365_b0095","first-page":"2361","article-title":"A Comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-\u03b1 converting enzyme: implications for selectivity","volume":"48","author":"Lukacova","year":"2010","journal-title":"J. Med."},{"key":"10.1016\/j.bioorg.2019.103365_b0100","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1021\/ja001461n","article-title":"Potent and selective mechanism-based inhibition of gelatinases","volume":"122","author":"Brown","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103365_b0105","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0960-894X(01)00419-X","article-title":"The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P11groups","volume":"11","author":"Levin","year":"2001","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103365_b0110","unstructured":"A. Eriksson, M. Lespisto, M. Lundkvist, M.M.A. Rosenschold, P. Zlatoidsky, Metalloproteinase Inhibitors, WO2002074750A1, 2004."},{"key":"10.1016\/j.bioorg.2019.103365_b0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/B978-0-444-63486-3.00014-1","article-title":"Endogenous and synthetic MMP inhibitors in CNS physiopathology","author":"Baranger","year":"2014","journal-title":"Brain Extracell. Matrix Heal. Dis."},{"key":"10.1016\/j.bioorg.2019.103365_b0120","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1537-1891(02)00201-X","article-title":"Drug transport to the brain: Key roles for the efflux pump P-glycoprotein in the blood-brain barrier","volume":"38","author":"Demeule","year":"2002","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.103365_b0125","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/acs.jmedchem.7b00237","article-title":"How big is too big for cell permeability?","volume":"60","author":"Matsson","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103365_b0130","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/0006-291X(72)90076-9","article-title":"On the size of the active site in proteases: Pronase","volume":"46","author":"Schechter","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2019.103365_b0135","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0006-291X(67)90299-9","article-title":"On the size of the active site in proteases II. Carboxypeptidase-A","author":"Abramowitz","year":"1967","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2019.103365_b0140","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jmb.2007.05.068","article-title":"Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity","volume":"371","author":"Tochowicz","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2019.103365_b0145","doi-asserted-by":"crossref","first-page":"310","DOI":"10.6026\/97320630005310","article-title":"Structural insights into the binding of MMP9 inhibitors","volume":"5","author":"Tandon","year":"2011","journal-title":"Bioinformation."},{"key":"10.1016\/j.bioorg.2019.103365_b0150","doi-asserted-by":"crossref","unstructured":"Y. Fu, J. Zhao, Z. Chen, Insights into the molecular mechanisms of protein-ligand interactions by molecular docking and molecular dynamics simulation: A case of oligopeptide binding protein, 98 (2018) 10089\u201310092. http:\/\/doi.org\/10.1155\/2018\/3502514.","DOI":"10.1155\/2018\/3502514"},{"key":"10.1016\/j.bioorg.2019.103365_b0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103365_b0160","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/jm800156z","article-title":"Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries","volume":"51","author":"Malakoutikhah","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103365_b0165","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1021\/acsmedchemlett.8b00098","article-title":"Modulating ADME properties by fluorination: MK2 inhibitors with improved oral exposure","volume":"9","author":"Velcicky","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103365_b0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1073\/pnas.91.1.68","article-title":"A method to determine the ability of drugs to diffuse through the blood-brain barrier","volume":"91","author":"Seelig","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2019.103365_b0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002329900434","article-title":"Blood-brain barrier permeation: molecular properties governing passive diffusion","volume":"165","author":"Fischer","year":"1998","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.bioorg.2019.103365_b0180","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mam.2008.08.001","article-title":"The ADAM metalloproteinases","volume":"29","author":"Edwards","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bioorg.2019.103365_b0185","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1367-5931(03)00084-X","article-title":"Prolyl peptidases: A serine protease subfamily with high potential for drug discovery","volume":"7","author":"Rosenblum","year":"2003","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2019.103365_b0190","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1002\/anie.201411408","article-title":"Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier","volume":"54","author":"Prades","year":"2015","journal-title":"Angew. Chemie - Int. Ed."},{"key":"10.1016\/j.bioorg.2019.103365_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0178943","article-title":"Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum","volume":"12","author":"Bo\u00f6ttger","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.bioorg.2019.103365_b0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2019.103365_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms5995","article-title":"Role for MMP-9 in stress-induced downregulation of nectin-3 in hippocampal CA1 and associated behavioural alterations","volume":"5","author":"Van Der Kooij","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2019.103365_b0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1517\/17425247.2016.1092519","article-title":"Brain\u2013blood ratio: implications in brain drug delivery","volume":"13","author":"Kulkarni","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bioorg.2019.103365_b0215","first-page":"1623","article-title":"Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier","volume":"1","author":"Stenehjem","year":"2009","journal-title":"Futur. Sci."},{"key":"10.1016\/j.bioorg.2019.103365_b0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1747-0285.2008.00632.x","article-title":"Metabolism of (4-phenoxyphenylsulfonyl)methylthiirane, a selective gelatinase inhibitor","volume":"71","author":"Celenza","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2019.103365_b0225","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4390","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibition?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2019.103365_b0230","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2019.103365_b0235","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/nar\/gkm276","article-title":"PDB2PQR: Expanding and upgrading automated preparation of biomolecular structures for molecular simulations","volume":"35","author":"Dolinsky","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2019.103365_b0240","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2019.103365_b0245","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: Fully automated protein-ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2019.103365_b0250","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/S0040-4039(97)00594-7","article-title":"N-Fmoc-aminooxy-2-chlorotrityl polystyrene resin: A facile solid-phase methodology for the synthesis of hydroxamic acids","volume":"38","author":"Mellor","year":"1997","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2019.103365_b0255","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1002\/chem.200900614","article-title":"Oxyma: An efficient additive for peptide synthesis to replace the benzotriazole-based HOBt and HOAt with a lower risk of explosion","volume":"15","author":"Subir\u00f3s-Funosas","year":"2009","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.bioorg.2019.103365_b0260","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0003-2697(70)90146-6","article-title":"Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides","volume":"34","author":"Kaiser","year":"1970","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2019.103365_b0265","first-page":"163","article-title":"A Qualitative Test for Monitoring Coupling Completness in Solid Phase Peptide Synthesis Using Chloranil","volume":"33","author":"Christensen","year":"1979","journal-title":"Acta Chem. Sca."},{"key":"10.1016\/j.bioorg.2019.103365_b0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4331\/wjbc.v2.i1.14","article-title":"Gelatin degradation assay reveals MMP-9 inhibitors and function of O-glycosylated domain","volume":"2","author":"Vandooren","year":"2011","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.103365_b0275","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/cbic.200500424","article-title":"Identification by 19F NMR of traditional Chinese medicinal plants possessing prolyl oligopeptidase inhibitory activity","volume":"7","author":"Tarrag\u00f3","year":"2006","journal-title":"ChemBioChem."},{"key":"10.1016\/j.bioorg.2019.103365_b0280","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.chembiol.2018.04.013","article-title":"Targeted covalent inhibition of Prolyl Oligopeptidase (POP): discovery of sulfonylfluoride peptidomimetics","volume":"25","author":"Guardiola","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bioorg.2019.103365_b0285","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103365_b0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1471-4159.2005.03543.x","article-title":"NMDA neuroprotection against a phosphatidylinositol-3 kinase inhibitor, LY294002 by NR2B-mediated suppression of glycogen synthase kinase-3b-induced apoptosis","volume":"96","author":"Habas","year":"2006","journal-title":"J. Neurochem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819309617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819309617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:50:19Z","timestamp":1777463419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819309617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":58,"alternative-id":["S0045206819309617"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103365","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103365"}}